On the nature of blocking factors and their lymphoid target cells in an allogeneic tumor system
- 30 June 1975
- journal article
- Published by Elsevier
- Vol. 11 (6) , 451-455
- https://doi.org/10.1016/0014-2964(75)90077-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Abrogation of cell‐mediated immunity by hyperimmune alloantiserum: Mechanisms and correlation with allograft enhancementInternational Journal of Cancer, 1974
- The immune response to primary moloney sarcoma virus tumors in BALB/C mice: Cellular and humoral activity of long-term regressorsInternational Journal of Cancer, 1974
- CELL-MEDIATED IMMUNITY AND BLOCKING SERUM ACTIVITY BEFORE AND AFTER BREAKAGE OF ALLOGRAFT TOLERANCE IN RATSTransplantation, 1973
- Increase of lymphocyte-mediated tumor-cell destruction by certain patient seraInternational Journal of Cancer, 1973
- CYTOTOXIC POTENTIAL OF MOUSE SPLEEN CELLS ON H-2 ANTIBODY-TREATED TARGET CELLSThe Journal of Experimental Medicine, 1973
- HETEROGENEITY OF THE EFFECTOR CELLS IN THE CYTOTOXIC REACTION AGAINST ALLOGENEIC LYMPHOMA CELLSThe Journal of Experimental Medicine, 1973
- Blocking of Lymphocyte-mediated Cytotoxicity for Rat Hepatoma Cells by Tumour-specific Antigen-Antibody ComplexesNature New Biology, 1972
- Antibody-Dependent Lymphoid Cell-Mediated Cytotoxicity: No Requirement for Thymus-Derived LymphocytesScience, 1972
- Brain-associated Θ antigen: Reactivity of rabbit anti-mouse brain with mouse lymphoid cellsCellular Immunology, 1971
- Immunological Enhancement as Studied by Cell Culture TechniquesAnnual Review of Microbiology, 1970